Adicet Bio, Inc.
▲ 0 upgrades / ▼ 0 downgrades / 2 reiterations from 2 firms
Nov 11, 2026 (16 days)
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Sep 29, 2026 | Wedbush | maintain | Outperform → Outperform | — | 58% |
| Sep 28, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Sep 18, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Aug 6, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| Mar 23, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Mar 13, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| Jan 21, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | $50 | 44% |
| Jan 6, 2026 | Canaccord Genuity | maintain | Buy → Buy | $18 | 48% |
| Nov 7, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $9 | 44% |
| Oct 8, 2025 | Guggenheim | maintain | Buy → Buy | $8 | 52% |
| Sep 19, 2025 | Guggenheim | reiterate | Buy → Buy | $7 | 52% |
| Mar 21, 2025 | Guggenheim | reiterate | Buy → Buy | $7 | 52% |
| Mar 7, 2025 | Citizens Capital Markets | reiterate | Market Perform → Market Perform | $0 | 49% |
| Mar 7, 2025 | HC Wainwright & Co. | reiterate | Neutral → Neutral | $0 | 44% |
| Feb 27, 2025 | HC Wainwright & Co. | reiterate | Neutral → Neutral | $0 | 44% |
| Feb 6, 2025 | JMP Securities | reiterate | Market Perform → Market Perform | $0 | 53% |
| Feb 5, 2025 | HC Wainwright & Co. | reiterate | Neutral → Neutral | $0 | 44% |
| Dec 19, 2024 | HC Wainwright & Co. | reiterate | Neutral → Neutral | $0 | 44% |
| Nov 18, 2024 | HC Wainwright & Co. | reiterate | — → Neutral | $0 | 44% |
| Aug 14, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| Aug 14, 2024 | Canaccord Genuity | maintain | Buy → Buy | $19 | 48% |
| Jul 8, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| Jun 24, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| Jun 5, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| May 15, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| Apr 23, 2024 | Wedbush | reiterate | Outperform → Outperform | $5 | 58% |
| Apr 2, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $10 | 44% |
| Mar 20, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| Mar 20, 2024 | Wedbush | reiterate | Outperform → Outperform | $5 | 58% |
| Mar 20, 2024 | Canaccord Genuity | reiterate | Buy → Buy | $19 | 48% |
| Feb 2, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $10 | 44% |
| Jan 5, 2024 | Canaccord Genuity | maintain | Buy → Buy | $19 | 48% |
| Nov 9, 2023 | Wedbush | maintain | Outperform → Outperform | $5 | 58% |
| Sep 6, 2023 | Truist Securities | reiterate | Buy → Buy | $27 | 54% |
| Aug 11, 2023 | HC Wainwright & Co. | maintain | Buy → Buy | $26 | 44% |
| Aug 10, 2023 | BTIG | maintain | Buy → Buy | $10 | 52% |
| Aug 10, 2023 | Wedbush | reiterate | Outperform → Outperform | $17 | 58% |
| Jun 27, 2023 | Guggenheim | downgrade | Buy → Neutral | $20 | 52% |
| Jun 27, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $38 | 44% |
| Jun 27, 2023 | JMP Securities | downgrade | Market Outperform → Market Perform | $0 | 53% |
| Jun 1, 2023 | JP Morgan | downgrade | Overweight → Neutral | $6 | 55% |
| May 15, 2023 | JMP Securities | reiterate | Market Outperform → Market Outperform | $19 | 53% |
| May 10, 2023 | Wedbush | reiterate | — → Outperform | $30 | 58% |
| May 10, 2023 | HC Wainwright & Co. | maintain | — → Buy | $38 | 44% |
| Mar 16, 2023 | Wedbush | reiterate | — → Outperform | $30 | 58% |
| Mar 16, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $38 | 44% |
| Dec 12, 2022 | HC Wainwright & Co. | maintain | — → Buy | $38 | 44% |
| Sep 21, 2022 | JP Morgan | initiate | — → Overweight | $23 | 55% |
| Mar 31, 2022 | SMBC Nikko | initiate | — → Outperform | $28 | — |
| Mar 17, 2022 | JMP Securities | maintain | — → Market Outperform | $21 | 53% |
No cross-platform signals in the last 90 days